Element Biosciences

Element Biosciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.elementbiosciences.com

Last Round

Series D

7/11/2024

Est. Valuation

$1B

Total Funding Raised

$683.3M

Company Overview

Element Biosciences is a biotechnology company that develops a modular and high-performing DNA sequencing platform designed to enhance research and diagnostics by providing quality data and workflow flexibility.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

DNA sequencingnext-generation sequencingNGSsequencing platformbenchtop sequencergene sequencerhigh-throughput sequencingmulti-omicsAvidity Base Chemistrysequencing consumablesgenomics hardwaregenomic workflowprecision medicinelong-read sequencinglibrary preparation kitsagrigenomicscyto-profiling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Element Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Element Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D7/11/2024
Series C6/29/2021
Series B Extension6/26/2020
Series B1/9/2020
Series A6/18/2019
Seed
9/11/2017

Key People

Founding team and executive leadership

Michael Previte

CTO, SVP R D, Co-founder

Founding Team

Logan Zinser

Chief Financial Officer (CFO)

Executive Team

Element Biosciences Investors

Notable investors and investment history

InvestorRounds
Janus Henderson GroupSeries C
RA Capital ManagementSeries B Extension, Series C
Fusion FundSeries D
Fidelity Management & Research CompanySeries D, Series C, Series B
Morgan StanleySeries C
Logos CapitalSeries C
Foresite CapitalSeries B, Seed, Series D, Series C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Achieved compliance with ISO 27001, ISO 9001, and ISO 13485 standards.

  • Mar 10, 2026

    Developing a multi-omics product for tissue samples.

Element Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Element Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Element Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range426
Year Founded2017
Last Funding7/11/2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.